RNA breakthroughs, Case Studies and Partnerships
September 23-24, 2026Thomas M. Menino Convention & Exhibition CenterMeet the past speakers
RNA Leaders USA covers the whole ecosystem and has talks, discussions and attendees from all RNA disciplines.
2023 speakers
| Heikki Lanckriet, CEO & CSO, 4Basebio |
| Amy Walker, VP of Research & Business Development, 4Basebio |
| Lykke Pedersen, Chief Pharma Officer, Abzu Aps |
| Eszter Békefi, Proposal Manager, AGC Biologics |
| Nate Spangler, CEO, Aldevron |
| Michelle Werner, CEO & Director, Alltrna |
| Vasant Jadhav, SVP, Head of RNAi Platform, Alnylam |
| Clara Assouline, Director, Business Development, Anima Biotech |
| Nicholas Marsh, Life Science Researcher, Arrakis Therapeutics |
| Frederic Legros, Executive Chairman & CEO, ARTHEx Biotech |
| Daniel Rosan, CEO, Ascidian Therapeutics |
| Annette Bak, Senior Director - Head of Advanced Drug Delivery, AstraZeneca |
| Sheri Ambriz, Senior Director - BD & Technical Solutio, Asymchem Inc |
| Vishal Doshi, Chairman, AUM Biosciences |
| Ariel Weinberger, CEO, Autonomous Therapeutics |
| Mike Flanagan, Co-Founder & CEO, Avidity Biosciences |
| Luis Brito, VP Delivery Platform, Beam Therapeutics |
| Yannick Fillon, Head of Oligonucleotide Process Chemistry, Biogen |
| Mark DeMario, CEO, BioNTech |
| Andreas Kuhn, SVP RNA Biochemistry & CMC Development, BioNTech |
| Gabriel Helmlinger, Associate Director, Scientific Strategy & Innovation, BIORCHESTRA |
| Josh Mandel-Brehm, CEO, Camp4 Therapeutics Corporation |
| Michael Rosenzweig, EVP, Capstan Therapeutics |
| Christopher Jewell, CSO, Cartesian Therapeutics |
| June Kim, Head of Targeted mRNA Delivery, CEPI (Coalition for Epidemic Preparedness and Innovation) |
| Javier Gimenez, Director, Certest Pharma |
| Shanthi Ganesh, Director, Discovery Research, Dicerna Pharmaceuticals |
| Iris Grossman, Principal, Eleven Therapeutics |
| Christalyn Rhodes, Associate VP- Genetic Medicine, External Partnerships & Collaborations, Eli Lilly |
| Malgorzata Gonciarz, CEO & Co-Founder, Eli Lilly |
| Tim Luker, VP Ventures, Eli Lilly |
| Akihiro Ko, CEO, Elixirgen Therapeutics |
| Dillon Flood, Co-Founder, Elsie Biotechnologies |
| Ryan Cross, Senior Science Correspondent, Endpoints News |
| Scott Laneman, Director of Innovation, Entegris |
| Leo Qian, Co-Founder & VP, Discovery Research, Entrada Therapeutics |
| Carsten Rudolph, CEO, Ethris |
| Patrick Thiaville, CTO, Exothera |
| Alex Philippidis, Senior Business Editor, Genetic Engineering & Biotechnology News |
| Kathleen Kean, Partner, Goodwin Procter |
| Matthew Hawryluk, Director of Product Management, Gritstone bio |
| Andrew Ferguson, VP Clinical Development, Gritstone bio |
| Leslie Williams, Co-Founder, Director, President & CEO, hC Bioscience |
| Nick Davis, mRNA Senior Scientist, HOVANA |
| David Slack, Senior Scientist, Impilo Therapeutics |
| Derek Hicks, CBO, Intellia Therapeutics |
| Eric Swayze, EVP, Research, Ionis Pharmaceuticals |
| Tamar Grossman, VP, Global Head of RNA, Gene Therapy & Delivery, Johnson & Johnson |
| Ram Aiyar, CEO, Korro Bio |
| Katerina Krumova, CFO, Laronde |
| Amy Espeseth, Head of Technical Operations, Laronde |
| Daniel Anderson, Professor, Massachusetts Institute of Technology |
| Daniel Quevedo, Senior Manager - Strategy & Business Development, METiS Therapeutics |
| Camden Cutright, Business Development Director, Micropore Technologies |
| Nagy Habib, Associate Director, Co-Founder, Chief Marketing Officer & Head of R&D, MiNA Therapeutics |
| Can Ozbal, CEO, Momentum Biotechnologies |
| Karin Kleinhans, Partner, MRLV |
| Jayesh Kulkarni, Business Developer Manager, NanoVation Therapeutics |
| Uli Stilz, Head of Bio Innovation Hub, Novo Nordisk |
| Mahesh Karande, VP Lilly Genetic Medicine, Omega Therapeutics |
| Thomas Barnes, CEO, Orna Therapeutics |
| Pallavi Lonkar, CTO, PepGen |
| Jing Zhu, VP of Nucleic Acid & Viral Vector Technology, Recipharm |
| Dominic Reynolds, SVP, Head of Drug Discovery, Remix Therapeutics |
| Sridhar Narayan, VP, Revir Therapeutics |
| Shraddha Sharma, Associate Director, Sanofi |
| Pierre Cote, Senior Director Strategic Partnerships & Innovation Management, mRNA CoE, Sanofi |
| Guillaume Pfefer, CEO & CSO, Senda Biosciences |
| Miroslav Gasparek, Co-Founder & CEO, Sensible Biotechnologies |
| Jimmy Weterings, VP of Research, Sirnaomics |
| Anna Perdrix Rosell, Founder & Co-CEO, Sixfold Bioscience |
| Huw Nash, Director, RNA Market Sectors Lead, Stoke Therapeutics |
| Dee Datta, CEO & Co-Founder, Switch Therapeutics |
| May Guo, Key Account Manager, Synthgene |
| Pedro Serrano, Senior Director & Head of Ribonucleic Acid & Protein Modulation, Takeda Pharmaceuticals |
| Matthias Hackl, CEO, TAmiRNA |
| David Davidson, VP Translational Neurology, Tessera Therapeutics |
| Angela Genge, Executive Director, Clinical Research Unit (CRU), The Montreal Neurological Institute |
| John Boyce, Co-Founder, Managing Director, TigerGene |
| Alicia Irurzun-Lafitte, Partner, UCB Ventures |
| Alex Kerr, Director of mRNA Platform, Unchained Labs |
| Aimee Edinger, Professor, University of California Irvine |
| Cesar Lopez-Camacho, Group Leader, University of Oxford |
| James Carroll, Managing Director, Wharton Alumni Angels |
| Dave Madge, VP Discovery Services, WuXi AppTec |
| Olivier Tytgat, Business Development Manager, Ziphius Vaccines |